Is Zolpidem Cognitive Impairment Reversible After Stopping?

The short answer

The label describes cognitive and psychomotor effects while zolpidem is active and the morning after a dose [2][5][3]. Evidence on recovery after stopping is limited to the trial described below [1].

What the label documents

Zolpidem is a GABA-A receptor positive modulator acting at the benzodiazepine site of alpha-1 subunit-containing receptors [2]. The label warns of next-day psychomotor impairment, including impaired driving, with risk rising with higher dose, less than 7 to 8 hours of sleep remaining, alcohol, other CNS depressants, and drugs that raise zolpidem levels [2]. Patients can be impaired the next morning even when they feel fully awake [3].

Complex sleep behaviors can occur after the first or any use, and patients usually do not remember them [2].

Does the effect fade as the drug clears?

The elimination half-life is about 2.5 hours (range 1.4 to 4.5) [2]. It is 9.9 hours in cirrhosis, and the label says to avoid zolpidem in severe hepatic impairment [2]. In 2013 the FDA lowered the recommended dose for women because morning blood levels may impair driving; it said risk is highest with extended-release products and that women eliminate zolpidem more slowly than men [3]. Current initial doses are 5 mg for women and 5 or 10 mg for men for immediate-release, and 6.25 mg for women and 6.25 or 12.5 mg for men for Ambien CR [2][5]. The Ambien CR label says pharmacodynamic tolerance or adaptation to some adverse depressant effects may develop during treatment [5].

What happened in the first nights after stopping

The 6-month trial enrolled adults aged 18 to 64 with chronic primary insomnia and assigned them to extended-release zolpidem 12.5 mg (669 patients) or placebo (349 patients), taken at least 3 and up to 7 nights per week [1]. No rebound effect was observed during the first 3 nights of discontinuation [1]. Cognitive outcomes after stopping were not among the results reported [1].

Withdrawal

The label says rapid dose reduction or abrupt discontinuation can cause withdrawal symptoms ranging from mild dysphoria and insomnia to cramps, vomiting, sweating, tremors, convulsions, and delirium, and it notes postmarketing reports of delirium with zolpidem use [2]. Dependence risk rises with higher dose, longer duration, and a history of alcohol or drug abuse [2].

Older adults

The 2023 AGS Beers Criteria recommend avoiding zolpidem in older adults because of delirium, falls, fractures, and crashes with minimal sleep benefit [6]. The label's dose for elderly or debilitated patients is 5 mg immediate-release or 6.25 mg Ambien CR once daily [2].